Midsona AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0000565228
SEK
8.70
0.1 (1.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Debt Company with a Debt to Equity ratio (avg) at times

  • Poor long term growth as Operating profit has grown by an annual rate -9.80% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Equity (avg) of 2.09% signifying low profitability per unit of shareholders funds
2

Poor long term growth as Operating profit has grown by an annual rate -9.80% of over the last 5 years

 
3

Risky -

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 1,224 Million (Small Cap)

stock-summary
P/E

31.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

14.21%

stock-summary
Debt Equity

0.15

stock-summary
Return on Equity

1.99%

stock-summary
Price to Book

0.42

Revenue and Profits:
Net Sales:
865 Million
(Quarterly Results - Jun 2025)
Net Profit:
-15 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
10.13%
0%
10.13%
6 Months
-2.25%
0%
-2.25%
1 Year
6.1%
0%
6.1%
2 Years
6.1%
0%
6.1%
3 Years
2.72%
0%
2.72%
4 Years
-81.47%
0%
-81.47%
5 Years
-87.71%
0%
-87.71%

Midsona AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.17%
EBIT Growth (5y)
-9.80%
EBIT to Interest (avg)
1.16
Debt to EBITDA (avg)
3.47
Net Debt to Equity (avg)
0.14
Sales to Capital Employed (avg)
1.02
Tax Ratio
41.54%
Dividend Payout Ratio
61.88%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.63%
ROE (avg)
2.09%
Valuation key factors
Factor
Value
P/E Ratio
31
Industry P/E
Price to Book Value
0.39
EV to EBIT
14.44
EV to EBITDA
6.14
EV to Capital Employed
0.47
EV to Sales
0.44
PEG Ratio
0.34
Dividend Yield
15.05%
ROCE (Latest)
3.25%
ROE (Latest)
1.26%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -5.77% vs 2.80% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -600.00% vs 109.38% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "865.00",
          "val2": "918.00",
          "chgp": "-5.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "42.00",
          "val2": "59.00",
          "chgp": "-28.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "11.00",
          "val2": "15.00",
          "chgp": "-26.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-11.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-15.00",
          "val2": "3.00",
          "chgp": "-600.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.90%",
          "val2": "24.00%",
          "chgp": "-1.71%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -1.74% vs -2.72% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 188.68% vs 89.42% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,727.00",
          "val2": "3,793.00",
          "chgp": "-1.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "281.00",
          "val2": "208.00",
          "chgp": "35.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "58.00",
          "val2": "74.00",
          "chgp": "-21.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-39.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "47.00",
          "val2": "-53.00",
          "chgp": "188.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "34.60%",
          "val2": "13.40%",
          "chgp": "2.12%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
865.00
918.00
-5.77%
Operating Profit (PBDIT) excl Other Income
42.00
59.00
-28.81%
Interest
11.00
15.00
-26.67%
Exceptional Items
-11.00
0.00
Consolidate Net Profit
-15.00
3.00
-600.00%
Operating Profit Margin (Excl OI)
6.90%
24.00%
-1.71%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is -5.77% vs 2.80% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -600.00% vs 109.38% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
3,727.00
3,793.00
-1.74%
Operating Profit (PBDIT) excl Other Income
281.00
208.00
35.10%
Interest
58.00
74.00
-21.62%
Exceptional Items
0.00
-39.00
100.00%
Consolidate Net Profit
47.00
-53.00
188.68%
Operating Profit Margin (Excl OI)
34.60%
13.40%
2.12%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -1.74% vs -2.72% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 188.68% vs 89.42% in Dec 2023

stock-summaryCompany CV
About Midsona AB stock-summary
stock-summary
Midsona AB
Pharmaceuticals & Biotechnology
Midsona AB, formerly Midelfart Sonesson AB is a Sweden-based company engaged in the development, manufacture and marketing of consumer healthcare products in the Nordic region. Its products are divided into three product areas: Healthfoods, Hygiene, Personal Care. The Company consists of three geographical areas, namely Sweden, Norway and Finland. The business areas in Sweden, Norway and Finland market and sell nutritional supplements, herbal remedies, health foods, skin care and beauty products to grocery stores, pharmacies and health stores in respective geographic markets. The Company has several priority brands, such as Friggs, Urtekram, Naturdiet, Miwana, MyggA, Dalblads, Tri Tolonen, Supernature.
Company Coordinates stock-summary
Company Details
Dockplatsen 16, Box 21009 , MALMO None : 200 21
stock-summary
Tel: 46 40 6602040
stock-summary
Registrar Details